Corient Capital Partners’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$504K Buy
25,748
+8,259
+47% +$137K 0.04% 337
2022
Q2
$342K Sell
17,489
-865
-5% -$18.1K 0.03% 437
2022
Q1
$398K Buy
18,354
+2,279
+14% +$48.3K 0.03% 434
2021
Q4
$379K Buy
16,075
+3,793
+31% +$90.8K 0.03% 446
2021
Q3
$321K Buy
12,282
+297
+2% +$7.18K 0.02% 472
2021
Q2
$290K Buy
+11,985
New +$295K 0.02% 492

Other funds holding SHC

Corient Capital Partners's SHC Position: Q3 2022 in Review

Corient Capital Partners increased its Sotera Health (SHC) stake by 47% in Q3 2022, buying an estimated $137K and bringing the position to 25,748 shares worth $504K. The position accounts for 0.04% of the portfolio, ranked #337.

Corient Capital Partners first reported a position in SHC in Q2 2021 and has held it in 6 quarters since. 184 funds tracked by Wall St. Rank hold SHC as of Q3 2022.

  • Corient Capital Partners held 25,748 shares of Sotera Health worth $504K as of Q3 2022.
  • Corient Capital Partners bought 8,259 Sotera Health shares in Q3 2022, an estimated $137K.
  • Sotera Health made up 0.04% of Corient Capital Partners's portfolio in Q3 2022, its #337 holding.
  • Corient Capital Partners first reported a position in Sotera Health in Q2 2021 and has held it in 6 quarters since.
  • 184 funds tracked by Wall St. Rank held Sotera Health as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.